SCHEMBL5178265

SCHEMBL5178265

Cn1cc2ccc(NC(=O)c3ccccc3NCc3ccnc(NC(=O)N4CCN(CCO)CC4)c3)cc2n1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KIT P10721 19/20 0.47
BRAF P15056 19/20 0.47
BRD4 O60885 1/20 0.40
CREBBP Q92793 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13714564 0.93 KIT (0.49) KITBRAFBRD4CREBBP
SCHEMBL13714592 0.90 KIT (0.50) KITBRAF
SCHEMBL13714601 0.90 KIT (0.48) KITBRAFBRD4CREBBP
SCHEMBL13714619 0.89 KIT (0.49) KITBRAFBRD4CREBBP
SCHEMBL13714621 0.89 KIT (0.47) KITBRAFBRD4CREBBP
SCHEMBL13714533 0.89 KIT (0.47) KITBRAFBRD4CREBBP
SCHEMBL5675460 0.88 KIT (0.47) KITBRAFBRD4CREBBP
SCHEMBL3866092 0.86 KIT (0.50) KITBRAF
SCHEMBL13714590 0.86 KIT (0.48) KITBRAFBRD4CREBBP
SCHEMBL13714532 0.86 KIT (0.48) KITBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807415-A2 NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VEGF RECEPTOR KINASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-18 EP claimed
WO-2006048248-A2 NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VEGF RECEPTOR KINASE IMHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-05-11 WO claimed